Taiwan Speciality Chemicals (4772.TWO) Earnings Analysis
Taiwan Speciality Chemicals (4772.TWO) next reports earnings on 2026-08-11, consensus EPS 1.66 TWD. Last quarter (2026-05-04) it missed with EPS 1.33 TWD vs 1.57 TWD est (-15.3%). It has beaten estimates in 0/4 recent quarters (0%). Trailing P/E 50.10.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4772.TWO next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | 1.66 TWD |
| Revenue estimate | 0.92B |
4772.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-04 | 1.33 TWD | 1.57 TWD | -15.3% | Miss |
| 2026-03-02 | 1.51 TWD | 1.53 TWD | -1.3% | Miss |
| 2025-11-03 | 1.21 TWD | 1.3 TWD | -6.9% | Miss |
| 2025-08-04 | 0.79 TWD | 0.845 TWD | -6.5% | Miss |
| 2024-12-31 | 0.892 TWD | n/a | n/a | n/a |
| 2024-09-30 | 0.71 TWD | n/a | n/a | n/a |
Beat rate: 0/4 (0%) over reported quarters with consensus data.
4772.TWO valuation and analyst view
| Trailing P/E | 50.10 |
|---|---|
| Trailing EPS | 3.91 TWD |
| Price / book | 13.98 |
| Dividend yield | 1.24% |
| Market cap | 35.81B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Taiwan Speciality Chemicals (4772.TWO)'s next earnings date?
Taiwan Speciality Chemicals is next scheduled to report on 2026-08-11, with a consensus EPS estimate of 1.66 TWD and revenue estimate of 0.92B.
Did 4772.TWO beat earnings last quarter?
In its 2026-05-04 report, 4772.TWO posted EPS of 1.33 TWD versus a 1.57 TWD estimate — a miss of 15.3%.
What is 4772.TWO's earnings track record?
Over the last 4 reported quarters with consensus data, 4772.TWO beat estimates 0 times (0%).
What is 4772.TWO's current P/E ratio and EPS?
4772.TWO trades at a trailing P/E of 50.10 on trailing EPS of 3.910195404534618 TWD.
What do analysts rate 4772.TWO?
4772.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.